Sean Patrick Thomas Murphy, Mb.Bch,Bao
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 14 | 2023 | 10900 | 1.420 |
Why?
|
Neprilysin | 2 | 2023 | 439 | 0.820 |
Why?
|
Stroke Volume | 11 | 2023 | 5007 | 0.810 |
Why?
|
Myocardial Infarction | 11 | 2023 | 11727 | 0.700 |
Why?
|
Atrial Natriuretic Factor | 1 | 2020 | 393 | 0.690 |
Why?
|
Cardiotonic Agents | 1 | 2020 | 535 | 0.590 |
Why?
|
Ventricular Remodeling | 2 | 2022 | 1224 | 0.590 |
Why?
|
Mitral Valve Insufficiency | 2 | 2024 | 1422 | 0.580 |
Why?
|
Heart Valve Diseases | 1 | 2024 | 1073 | 0.540 |
Why?
|
Myocarditis | 5 | 2021 | 771 | 0.530 |
Why?
|
International Classification of Diseases | 2 | 2019 | 867 | 0.510 |
Why?
|
Drug Combinations | 5 | 2023 | 1959 | 0.490 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2024 | 1536 | 0.450 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.440 |
Why?
|
Hypertension, Pulmonary | 1 | 2024 | 1537 | 0.440 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2020 | 2073 | 0.430 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 45 | 0.420 |
Why?
|
Primary Prevention | 1 | 2019 | 1167 | 0.400 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2376 | 0.370 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.360 |
Why?
|
Biphenyl Compounds | 4 | 2022 | 913 | 0.360 |
Why?
|
Tetrazoles | 4 | 2023 | 835 | 0.350 |
Why?
|
Angiotensin Receptor Antagonists | 4 | 2023 | 924 | 0.340 |
Why?
|
Ventricular Function, Left | 6 | 2022 | 3670 | 0.310 |
Why?
|
Heart | 1 | 2021 | 4467 | 0.310 |
Why?
|
Proteomics | 1 | 2021 | 3638 | 0.300 |
Why?
|
Heart Defects, Congenital | 1 | 2024 | 4584 | 0.290 |
Why?
|
Aspirin | 1 | 2019 | 3282 | 0.290 |
Why?
|
Registries | 4 | 2021 | 8089 | 0.280 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 3068 | 0.270 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2337 | 0.270 |
Why?
|
Prognosis | 9 | 2023 | 29063 | 0.210 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.200 |
Why?
|
Coronary Vasospasm | 1 | 2022 | 88 | 0.200 |
Why?
|
Inflammation | 2 | 2022 | 10638 | 0.200 |
Why?
|
Receptors, Angiotensin | 1 | 2021 | 142 | 0.190 |
Why?
|
Diuretics | 2 | 2022 | 592 | 0.190 |
Why?
|
Angiotensins | 1 | 2021 | 151 | 0.190 |
Why?
|
Plaque, Atherosclerotic | 2 | 2023 | 1519 | 0.180 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2022 | 138 | 0.180 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 290 | 0.170 |
Why?
|
Humans | 36 | 2024 | 744343 | 0.170 |
Why?
|
Competency-Based Education | 1 | 2020 | 211 | 0.160 |
Why?
|
Spironolactone | 1 | 2021 | 382 | 0.150 |
Why?
|
Coronary Stenosis | 1 | 2023 | 834 | 0.150 |
Why?
|
Heart Injuries | 1 | 2019 | 210 | 0.150 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.150 |
Why?
|
Heart Atria | 1 | 2022 | 1357 | 0.140 |
Why?
|
Patient Care Management | 1 | 2019 | 306 | 0.130 |
Why?
|
Aged | 14 | 2023 | 163280 | 0.130 |
Why?
|
Mitral Valve | 1 | 2024 | 1491 | 0.130 |
Why?
|
Heart Conduction System | 1 | 2021 | 1047 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2022 | 832 | 0.130 |
Why?
|
Health Status Indicators | 1 | 2020 | 969 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1855 | 0.120 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15165 | 0.120 |
Why?
|
Physical Examination | 1 | 2020 | 1237 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 7913 | 0.110 |
Why?
|
Action Potentials | 1 | 2021 | 1806 | 0.110 |
Why?
|
Coronary Artery Disease | 2 | 2023 | 6487 | 0.110 |
Why?
|
Patient Readmission | 3 | 2023 | 3114 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7279 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1257 | 0.100 |
Why?
|
Influenza Vaccines | 1 | 2019 | 738 | 0.100 |
Why?
|
Echocardiography | 2 | 2022 | 5102 | 0.100 |
Why?
|
Defibrillators, Implantable | 1 | 2020 | 1440 | 0.100 |
Why?
|
Middle Aged | 13 | 2023 | 213383 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1912 | 0.090 |
Why?
|
Patient Discharge | 2 | 2020 | 3313 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.090 |
Why?
|
Risk Assessment | 6 | 2021 | 23338 | 0.090 |
Why?
|
Heart Rate | 1 | 2021 | 4091 | 0.090 |
Why?
|
Health Status | 1 | 2022 | 4034 | 0.080 |
Why?
|
Male | 15 | 2023 | 350118 | 0.080 |
Why?
|
Influenza, Human | 1 | 2019 | 1479 | 0.080 |
Why?
|
Electrocardiography | 1 | 2021 | 6442 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.070 |
Why?
|
Female | 14 | 2023 | 380194 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 63114 | 0.070 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.070 |
Why?
|
Prevalence | 2 | 2020 | 15226 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2968 | 0.060 |
Why?
|
Risk Factors | 6 | 2022 | 72290 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3445 | 0.060 |
Why?
|
Clinical Competence | 1 | 2020 | 4687 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2022 | 1573 | 0.060 |
Why?
|
Anticoagulants | 1 | 2019 | 4599 | 0.060 |
Why?
|
Technetium Tc 99m Pyrophosphate | 1 | 2022 | 44 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2020 | 964 | 0.060 |
Why?
|
Diphosphates | 1 | 2022 | 88 | 0.050 |
Why?
|
Technetium | 1 | 2022 | 334 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2023 | 15076 | 0.050 |
Why?
|
Prealbumin | 1 | 2022 | 210 | 0.050 |
Why?
|
Nitrates | 1 | 2022 | 265 | 0.050 |
Why?
|
Ireland | 1 | 2020 | 161 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1107 | 0.040 |
Why?
|
Enalapril | 1 | 2022 | 327 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2022 | 77449 | 0.040 |
Why?
|
Internship and Residency | 1 | 2020 | 5788 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 690 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2022 | 2031 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.040 |
Why?
|
Troponin I | 1 | 2022 | 619 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2022 | 977 | 0.040 |
Why?
|
Fluorouracil | 1 | 2022 | 1619 | 0.040 |
Why?
|
Troponin T | 1 | 2022 | 754 | 0.040 |
Why?
|
Boston | 2 | 2020 | 9313 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13695 | 0.040 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 841 | 0.030 |
Why?
|
Massachusetts | 2 | 2019 | 8663 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10252 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 952 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 935 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2309 | 0.030 |
Why?
|
Time Factors | 3 | 2021 | 40075 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.030 |
Why?
|
Chest Pain | 1 | 2020 | 1114 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2917 | 0.030 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2023 | 4577 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3778 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2020 | 3760 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7149 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
Students, Medical | 1 | 2020 | 1862 | 0.020 |
Why?
|
Contrast Media | 1 | 2020 | 5300 | 0.020 |
Why?
|
Curriculum | 1 | 2020 | 3605 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3278 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3229 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 40561 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3255 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5317 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10388 | 0.020 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.010 |
Why?
|
United States | 2 | 2020 | 69872 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5510 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20129 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13102 | 0.010 |
Why?
|